Ticker Scorecard - ALXO Basics Company: ALX Oncology Holdings Inc. IPO Date: July 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $69.62M Activated in VL: True Average Daily Range Avg Daily Range: $0.94 | 3.90% Avg Daily Range (30 D): $0.09 | 5.52% Avg Daily Range (90 D): $0.07 | 4.64% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): 1.08M Avg Daily Volume (90 D): .86M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 202 Avg Trade Size (Sh.) (90 D): 184 Institutional Trades Total Inst.Trades: 825 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $1.08M Avg Inst. Trade (90 D): $1.11M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $.83M Avg Closing Trade (90 D): $.83M Avg Closing Volume: 74.95K     News Dec 18, 2024 @ 1:00 PM ALX Oncology to Present Updated Results from Phase... Source: Alx Oncology Nov 1, 2024 @ 9:30 PM ALX Oncology Announces Results from Phase 1b/2 Tri... Source: Alx Oncology Oct 1, 2024 @ 5:00 PM Breast Cancer Clinical Trial Pipeline Appears Robu... Source: Delveinsight Jul 24, 2024 @ 8:02 AM EnerVenue Names Steffen Pietzke as Chief Financial... Source: N/A Jul 3, 2024 @ 6:30 PM Cartesian (RNAC) MG Study Meets Goals, Stock Down ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.97 $-.58 $-.76 Diluted EPS $-2.97 $-.58 $-.76 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -151.16M $ -30.71M $ -39.4M Operating Income / Loss $ -159.88M $ -32.57M $ -41.53M Cost of Revenue $ $ $ Net Cash Flow $ -3.48M $ .57M $ 1.49M PE Ratio